IS7195A - Ný vatnsfrí kristallaform af gabapentíni - Google Patents
Ný vatnsfrí kristallaform af gabapentíniInfo
- Publication number
- IS7195A IS7195A IS7195A IS7195A IS7195A IS 7195 A IS7195 A IS 7195A IS 7195 A IS7195 A IS 7195A IS 7195 A IS7195 A IS 7195A IS 7195 A IS7195 A IS 7195A
- Authority
- IS
- Iceland
- Prior art keywords
- gabapentin
- crystalline form
- anhydrous crystalline
- new anhydrous
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32837501P | 2001-10-09 | 2001-10-09 | |
| US10/256,155 US6800782B2 (en) | 2001-10-09 | 2002-09-25 | Anhydrous crystalline forms of gabapentin |
| PCT/US2002/031706 WO2003031391A1 (en) | 2001-10-09 | 2002-10-03 | New anhydrous crystalline forms of gabapentin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7195A true IS7195A (is) | 2004-03-23 |
Family
ID=26945177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7195A IS7195A (is) | 2001-10-09 | 2004-03-23 | Ný vatnsfrí kristallaform af gabapentíni |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6800782B2 (is) |
| EP (1) | EP1463712A1 (is) |
| JP (1) | JP2005505594A (is) |
| KR (1) | KR20050033525A (is) |
| CN (1) | CN1568305A (is) |
| AP (1) | AP2004003025A0 (is) |
| BG (1) | BG108702A (is) |
| BR (1) | BR0213156A (is) |
| CA (1) | CA2462331A1 (is) |
| CO (1) | CO5570697A2 (is) |
| CZ (1) | CZ2004416A3 (is) |
| EA (1) | EA006557B1 (is) |
| GE (1) | GEP20063936B (is) |
| HR (1) | HRP20040408A2 (is) |
| HU (1) | HUP0401782A3 (is) |
| IL (1) | IL161099A0 (is) |
| IS (1) | IS7195A (is) |
| MA (1) | MA27072A1 (is) |
| MX (1) | MXPA04003301A (is) |
| NO (1) | NO20041370L (is) |
| NZ (1) | NZ531993A (is) |
| OA (1) | OA12665A (is) |
| PL (1) | PL368117A1 (is) |
| RS (1) | RS28204A (is) |
| SK (1) | SK1572004A3 (is) |
| TN (1) | TNSN04055A1 (is) |
| WO (1) | WO2003031391A1 (is) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070043236A1 (en) * | 2003-05-19 | 2007-02-22 | Chandiran Thakashina M | Process for preparation of gabapentin |
| WO2004106281A1 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Crystalline gabapentin |
| WO2004110342A2 (en) * | 2003-06-12 | 2004-12-23 | Matrix Laboratories Ltd | Novel polymorph of gabapentin and its conversion to gabapentin form-ii |
| US7169812B2 (en) * | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
| ITMI20040579A1 (it) * | 2004-03-25 | 2004-06-25 | Zambon Spa | Processo di preparazione di gabapentina |
| WO2010023694A2 (en) * | 2008-09-01 | 2010-03-04 | Hikal Ltd | Crystalline forms of gabapentin and process thereof |
| CN104649921B (zh) * | 2015-01-14 | 2016-09-28 | 天津大学 | 一种加巴喷丁与己二酸共晶及其制备方法 |
| CN116693410A (zh) * | 2023-06-08 | 2023-09-05 | 浙江竹子制药有限公司 | 一种粒径可控的加巴喷丁制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| JPS62247160A (ja) * | 1986-03-31 | 1987-10-28 | Aisin Seiki Co Ltd | スタ−リングエンジンの始動装置 |
| US4960931A (en) | 1988-05-02 | 1990-10-02 | Warner-Lambert Company | Gabapentin mohohydrate and a process for producing the same |
| US4894476A (en) | 1988-05-02 | 1990-01-16 | Warner-Lambert Company | Gabapentin monohydrate and a process for producing the same |
| DE3928184A1 (de) | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
| IL119890A (en) | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
| ES2137137B1 (es) | 1998-05-25 | 2000-08-16 | Medichem Sa | Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. |
-
2002
- 2002-09-25 US US10/256,155 patent/US6800782B2/en not_active Expired - Fee Related
- 2002-10-03 AP APAP/P/2004/003025A patent/AP2004003025A0/en unknown
- 2002-10-03 IL IL16109902A patent/IL161099A0/xx unknown
- 2002-10-03 GE GE5594A patent/GEP20063936B/en unknown
- 2002-10-03 BR BR0213156-0A patent/BR0213156A/pt not_active IP Right Cessation
- 2002-10-03 JP JP2003534375A patent/JP2005505594A/ja active Pending
- 2002-10-03 PL PL02368117A patent/PL368117A1/xx not_active Application Discontinuation
- 2002-10-03 CZ CZ2004416A patent/CZ2004416A3/cs unknown
- 2002-10-03 OA OA1200400095A patent/OA12665A/en unknown
- 2002-10-03 HU HU0401782A patent/HUP0401782A3/hu unknown
- 2002-10-03 RS YU28204A patent/RS28204A/sr unknown
- 2002-10-03 CN CNA02820056XA patent/CN1568305A/zh active Pending
- 2002-10-03 NZ NZ531993A patent/NZ531993A/en unknown
- 2002-10-03 KR KR1020047005149A patent/KR20050033525A/ko not_active Application Discontinuation
- 2002-10-03 SK SK157-2004A patent/SK1572004A3/sk not_active Application Discontinuation
- 2002-10-03 EA EA200400417A patent/EA006557B1/ru not_active IP Right Cessation
- 2002-10-03 MX MXPA04003301A patent/MXPA04003301A/es active IP Right Grant
- 2002-10-03 EP EP02766485A patent/EP1463712A1/en not_active Withdrawn
- 2002-10-03 WO PCT/US2002/031706 patent/WO2003031391A1/en active Application Filing
- 2002-10-03 CA CA002462331A patent/CA2462331A1/en not_active Abandoned
-
2004
- 2004-03-23 IS IS7195A patent/IS7195A/is unknown
- 2004-04-01 NO NO20041370A patent/NO20041370L/no not_active Application Discontinuation
- 2004-04-05 MA MA27606A patent/MA27072A1/fr unknown
- 2004-04-06 CO CO04032599A patent/CO5570697A2/es not_active Application Discontinuation
- 2004-04-07 TN TNP2004000055A patent/TNSN04055A1/fr unknown
- 2004-04-28 BG BG108702A patent/BG108702A/xx unknown
- 2004-05-07 HR HR20040408A patent/HRP20040408A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20040408A2 (en) | 2004-10-31 |
| CO5570697A2 (es) | 2005-10-31 |
| EA200400417A1 (ru) | 2004-10-28 |
| KR20050033525A (ko) | 2005-04-12 |
| BG108702A (en) | 2005-05-31 |
| AP2004003025A0 (en) | 2004-06-30 |
| US6800782B2 (en) | 2004-10-05 |
| TNSN04055A1 (fr) | 2006-06-01 |
| IL161099A0 (en) | 2004-08-31 |
| NO20041370L (no) | 2004-04-01 |
| BR0213156A (pt) | 2004-09-14 |
| HUP0401782A3 (en) | 2006-01-30 |
| MA27072A1 (fr) | 2004-12-20 |
| CZ2004416A3 (cs) | 2005-03-16 |
| EA006557B1 (ru) | 2006-02-24 |
| US20030092933A1 (en) | 2003-05-15 |
| PL368117A1 (en) | 2005-03-21 |
| SK1572004A3 (sk) | 2005-03-04 |
| MXPA04003301A (es) | 2004-07-23 |
| HUP0401782A2 (hu) | 2005-10-28 |
| NZ531993A (en) | 2006-09-29 |
| WO2003031391A1 (en) | 2003-04-17 |
| OA12665A (en) | 2006-06-19 |
| CA2462331A1 (en) | 2003-04-17 |
| CN1568305A (zh) | 2005-01-19 |
| GEP20063936B (en) | 2006-10-10 |
| EP1463712A1 (en) | 2004-10-06 |
| RS28204A (en) | 2006-12-15 |
| JP2005505594A (ja) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7007A (is) | Kristallaform af asiþrómýsíni | |
| DK1451192T3 (da) | Ny krystallinsk forbindelse | |
| DK1438306T3 (da) | Derivater af UK-2A | |
| DK2251344T4 (da) | Formulering af boronsyreforbindelser | |
| DK1360169T3 (da) | Succinatsalt af O-desmethyl-venlafaxin | |
| DK2343275T3 (da) | Krystallinsk form af optiske enantiomerer af modafinil | |
| FI7526U1 (fi) | Kiteinen bikalutamidi | |
| DK1522539T3 (da) | Krystallinsk komposition indeholdende excitalopram | |
| DK1250311T3 (da) | Asymmetrisk syntese af pregabalin | |
| DK1417180T3 (da) | Fremstilling af aminopyrimidinforbindelser | |
| FI20021262A0 (fi) | Sokerien kiteytys | |
| DK1487832T3 (da) | Krystallinsk mikronisat af tiotropiumbromid | |
| DK1458447T3 (da) | Kombination af cytokrom-p450-beroende proteasinhibitorer | |
| DK1401828T3 (da) | N-Formylhydroxylaminforbindelser som inhibitorer af PDF | |
| IS6868A (is) | Ný pýrimidínefnasambönd | |
| ATE364610T1 (de) | Kristalline polymorphe form von irinotecan- hyrochlorid | |
| DK1353923T3 (da) | Forbedret fremgangsmåde til syntese af carbapenem | |
| DK1578774T3 (da) | Oprensning af immunoglobuliner | |
| DK1377544T3 (da) | Oprensning af 2-nitro-4-methylsulfonylbenzoesyre | |
| IS7195A (is) | Ný vatnsfrí kristallaform af gabapentíni | |
| NO20035713D0 (no) | Forbindelsesforankring | |
| NO20030416D0 (no) | Krystallinsk terapeutisk forbindelse | |
| NO20044364L (no) | Hydroksykarbamimidoyl-2-hydroksy-benzensulfonamidderivat-krystaller | |
| DE60112036D1 (de) | Uhrwerk | |
| DK1503987T3 (da) | Fremstilling af en vandfri quinolinbaseret CETP inhibitor ved krystallisering |